Cargando…

Clinical Outcomes from Dose-Reduced Radiotherapy to the Prostate in Elderly Patients with Localized Prostate Cancer

Radical treatment of localized prostate cancer in elderly patients may lead to unacceptable treatment-associated toxicities that adversely impact quality of life without improving survival outcomes. This study reports on a cohort of 54 elderly (>70 years) patients that received 4000–5000 cGy of p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Samson, Nina, Khanolkar, Rutvij A., Quirk, Sarah, Quon, Harvey, Roumeliotis, Michael, Balogh, Alex, Sia, Michael, Thind, Kundan, Husain, Siraj, Martell, Kevin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8534720/ https://www.ncbi.nlm.nih.gov/pubmed/34677236 http://dx.doi.org/10.3390/curroncol28050318

Ejemplares similares

Excessive waitlists and delays to treatment with low-dose-rate brachytherapy predict an increased risk of recurrence and metastases in intermediate-risk prostatic carcinoma
por: Khanolkar, Rutvij A., et al.
Publicado: (2021)

Rapid implementation of extreme hypofractionation protocols in prostate cancer using RapidPlan® in response to COVID-19
por: Martell, Kevin, et al.
Publicado: (2020)

Analysis of outcomes after non-contour-based dose painting of dominant intra-epithelial lesion in intra-operative low-dose rate brachytherapy()
por: Martell, Kevin, et al.
Publicado: (2020)

Parameters predicting for prostate specific antigen response rates at one year post low-dose-rate intraoperative prostate brachytherapy
por: Martell, Kevin, et al.
Publicado: (2017)

Indications for additional volume studies for gland volume estimation in prostate cancer brachytherapy
por: Khanolkar, Rutvij A, et al.
Publicado: (2022)

MRI‐TRUS registration methodology for TRUS‐guided HDR prostate brachytherapy
por: McGeachy, Philip, et al.
Publicado: (2021)

Assessment of dose to vaginal mucosa for gynecologic template interstitial high-dose-rate brachytherapy using Monte Carlo simulation
por: Elburg, Devin Van, et al.
Publicado: (2023)

The impact of inter-fraction changes for perineal template-based interstitial gynecologic brachytherapy implants
por: Belliveau, Jean-Guy, et al.
Publicado: (2019)

Performance of a knowledge‐based planning model for optimizing intensity‐modulated radiotherapy plans for partial breast irradiation
por: Frederick, Amy, et al.
Publicado: (2021)

Type and dose of radiotherapy used for initial treatment of non-metastatic prostate cancer
por: Wang, Dian, et al.
Publicado: (2014)

A framework for clinical commissioning of 3D‐printed patient support or immobilization devices in photon radiotherapy
por: Meyer, Tyler, et al.
Publicado: (2018)

Hypofractionated radiotherapy for prostate cancer
por: Hegemann, Nina-Sophie, et al.
Publicado: (2014)

Radiotherapy in nodal oligorecurrent prostate cancer
por: Pinkawa, Michael, et al.
Publicado: (2021)

Image guided dose escalated prostate radiotherapy: still room to improve
por: Martin, Jarad M, et al.
Publicado: (2009)

Intrafraction Prostate Motion Management for Ultra-Hypofractionated Radiotherapy of Prostate Cancer
por: Oehler, Christoph, et al.
Publicado: (2022)

Dose mapping sensitivity to deformable registration uncertainties in fractionated radiotherapy – applied to prostate proton treatments
por: Tilly, David, et al.
Publicado: (2013)

The effects of motion on the dose distribution of proton radiotherapy for prostate cancer
por: Qamhiyeh, Sima, et al.
Publicado: (2012)

Post-implant analysis in permanent breast seed implant: automated plan reconstruction using simulated annealing
por: Watt, Elizabeth, et al.
Publicado: (2019)

Correction: Image guided dose escalated prostate radiotherapy: still room to improve
por: Martin, Jarad M, et al.
Publicado: (2009)

Distinguishing prostate-specific antigen bounces from biochemical failure after low-dose-rate prostate brachytherapy
por: Hackett, Cian, et al.
Publicado: (2014)

Ablative Radiotherapy in Prostate Cancer: Stereotactic Body Radiotherapy and High Dose Rate Brachytherapy
por: Ma, Ting Martin, et al.
Publicado: (2020)

The Effect of Radiotherapy on the Concentration of Plasma Lipids in Elderly Prostate Cancer Patients
por: Wolny-Rokicka, Edyta, et al.
Publicado: (2019)

Associations between voxel-level accumulated dose and rectal toxicity in prostate radiotherapy
por: Shelley, Leila E.A., et al.
Publicado: (2020)

Neural network dose prediction for rectal spacer stratification in dose‐escalated prostate radiotherapy
por: Thomas, Christopher, et al.
Publicado: (2022)

Dose-Escalated Salvage Radiotherapy for Macroscopic Local Recurrence of Prostate Cancer in the Prostate-Specific Membrane Antigen Positron Emission Tomography Era
por: Tamihardja, Jörg, et al.
Publicado: (2022)

Toxicity of dose-escalated radiotherapy up to 84 Gy for prostate cancer
por: Rosenbrock, Johannes, et al.
Publicado: (2023)

Dose-Escalated Stereotactic Body Radiation Therapy for Prostate Cancer: Quality-of-Life Comparison of Two Prospective Trials
por: Quon, Harvey C., et al.
Publicado: (2016)

Comparison of Oncological Outcomes Between Radical Prostatectomy and Radiotherapy by Type of Radiotherapy in Elderly Prostate Cancer Patients
por: Guo, Xiao-Xiao, et al.
Publicado: (2021)

MRI-guided Dose-escalated Salvage Radiotherapy for Bulky Bladder Neck Recurrence of Prostate Cancer
por: Kishan, Amar U, et al.
Publicado: (2018)

Emerging evidence for non-pharmacologic interventions in reducing the burden of respiratory illnesses
por: Khanolkar, Rutvij A., et al.
Publicado: (2022)

Study of peripheral dose from low-dose CT to adaptive radiotherapy of postoperative prostate cancer
por: Gan, Guanghui, et al.
Publicado: (2023)

Long-Term Outcomes of Dose-Escalated Hypofractionated Radiotherapy in Localized Prostate Cancer
por: Lazo, Antonio, et al.
Publicado: (2022)

Assessing radiation dose for postoperative radiotherapy in prostate cancer: Real world data
por: Hervás-Morón, Asunción, et al.
Publicado: (2022)

Gastrointestinal and genitourinary toxicity profiles of metformin versus placebo in men with prostate cancer receiving prostate radiotherapy: interim toxicity results of a double-blinded, multicenter, phase II randomized controlled trial
por: Kim, Julian O., et al.
Publicado: (2021)

Safety and Efficacy of Carbon-Ion Radiotherapy for Elderly Patients with High-Risk Prostate Cancer
por: Hiroshima, Yuichi, et al.
Publicado: (2022)

RADIOTHERAPY OF PROSTATE CANCER: PRIMARY RADIOTHERAPY AND RADIOTHERAPY IN DISEASE RELAPSE
por: Antunac, Katarina
Publicado: (2019)

Automated prediction of dosimetric eligibility for hypofractionated prostate radiotherapy
por: Lausch, Anthony, et al.
Publicado: (2017)

Cone beam CT-based dose accumulation and analysis of delivered dose to the dominant intraprostatic lesion in primary radiotherapy of prostate cancer
por: Tamihardja, Jörg, et al.
Publicado: (2021)

Equivalent normalized total dose estimates in cyberknife radiotherapy dose delivery in prostate cancer hypofractionation regimens
por: Sudahar, H., et al.
Publicado: (2012)

Delivered dose can be a better predictor of rectal toxicity than planned dose in prostate radiotherapy
por: Shelley, L.E.A., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_ecjdi088leov6f02mul5pg6neh